Population pharmacokinetics of unbound imipenem in critically ill patients: a comparison of five renal function estimators for PK/PD-guided dosing
European Journal of Clinical Pharmacology · 2026-07 · 82 (7)
DOI: 10.1007/s00228-026-04096-6 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 11.06.2026. Verfasst von Apinya Boonpeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, 56000, Thailand. apinya.bo@up.ac.th. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Imipenem, Models, Biological, Cilastatin, Imipenem Drug Combination. Die Arbeit nennt 27 Literaturangaben. Gefördert von: the Thailand Science Research and Innovation Fund, the University of Phayao, Graduate School, Prince of Songkla University, Thailand, Faculty of Medicine,Prince of Songkla University, Thailand..
Abstract (Originalsprache)
BACKGROUND: Optimizing imipenem therapy in intensive care patients presents challenges due to pathophysiological changes affecting drug disposition. This study developed a population pharmacokinetics model, determined optimal dosing strategies, and described the observed pharmacokinetic/pharmacodynamic (PK/PD) target attainment and clinical outcomes. METHODS: Critically ill patients receiving imipenem/cilastatin were enrolled prospectively. Five blood samples per patient were collected within 24-48 h of treatment initiation. Nonlinear mixed-effects modeling characterized drug pharmacokinetics, with Monte Carlo simulations assessing target attainment probabilities. RESULTS: The study enrolled 21 critically ill patients. A two-compartment model with first-order elimination optimally described imipenem pharmacokinetics, with estimated parameters including total clearance (8.75 L/h), intercompartmental clearance (15.9 L/h), central volume (15.2 L), and peripheral volume (23.4 L). Among evaluated covariates, only estimated glomerular filtration rate (using CKD-EPI 2021 equation) significantly influenced drug clearance. Probability of target attainment analysis (PTA) demonstrated that conventional dosing regimens provided ≥ 90% probability of achieving 40% free time above MIC (fT > MIC) for organisms with MIC values ≤ 2 mg/L. Achieving 75% fT > MIC required maximum conventional doses, whereas 100% fT > MIC with adequate PTA (≥ 80%) necessitated continuous infusion strategies employing doses 30-50% above standard recommendations. Clinical success was observed in 23% of patients (3/13), with higher fT > MIC values among successful cases. However, treatment failure still occurred in some patients despite achieving 100% fT > MIC, suggesting multifactorial determinants of outcomes in critically ill patients. CONCLUSION: Renal function significantly influences imipenem clearance. While standard dosing provides sufficient coverage for conventional PK/PD targets, continuous infusions should be considered for more aggressive targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, 56000, Thailand. apinya.bo@up.ac.th.
- Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand.
Förderung
- the Thailand Science Research and Innovation Fund, the University of Phayao
- Graduate School, Prince of Songkla University, Thailand
- Faculty of Medicine,Prince of Songkla University, Thailand.
Zitieren
APA
Boonpeng, A., Jaruratanasirikul, S., Jullangkoon, M., & Samaeng, M. (2026). Population pharmacokinetics of unbound imipenem in critically ill patients: a comparison of five renal function estimators for PK/PD-guided dosing. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04096-6
Vancouver
Boonpeng A, Jaruratanasirikul S, Jullangkoon M, Samaeng M. Population pharmacokinetics of unbound imipenem in critically ill patients: a comparison of five renal function estimators for PK/PD-guided dosing. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04096-6
BibTeX
@article{Boonpeng2026,
author = {Boonpeng, Apinya and Jaruratanasirikul, Sutep and Jullangkoon, Monchana and Samaeng, Maseetoh},
title = {Population pharmacokinetics of unbound imipenem in critically ill patients: a comparison of five renal function estimators for PK/PD-guided dosing},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {7},
doi = {10.1007/s00228-026-04096-6}
}
EUVIMED